Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior. 2022

Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
Centro Cardiologico Monzino, Istituto di Ricerca e Cura a Carattere Scientifico, 20138 Milan, Italy.

Several contributions of circulating microvesicles (MVs) to the endothelial dysfunction have been reported in the past; a head-to-head comparison of platelet- and monocyte-derived MVs has however never been performed. To this aim, we assessed the involvement of these MVs in vessel damage related processes, i.e., oxidative stress, inflammation, and leukocyte-endothelial adhesion. Platelets and monocytes isolated from healthy subjects (HS, n = 15) were stimulated with TRAP-6 and LPS to release MVs that were added to human vascular endothelial cell (hECV) culture to evaluate superoxide anion production, inflammatory markers (IL-6, TNFα, NF-κB mRNA expression), and hECV adhesiveness. The effects of the MVs-induced from HS were compared to those induced by MVs spontaneously released from cells of patients with ST-segment elevation myocardial infarction (STEMI, n = 7). MVs released by HS-activated cells triggered a threefold increase in oxidative burst in a concentration-dependent manner. Only MVs released from monocytes doubled IL-6, TNFα, and NF-κB mRNA expression and monocyte-endothelial adhesion. Interestingly, the effects of the MVs isolated from STEMI-monocytes were not superimposable to previous ones except for adhesion to hECV. Conversely, MVs released from STEMI-platelets sustained both redox state and inflammatory phenotype. These data provide evidence that MVs released from activated and/or pathologic platelets and monocytes differently affect endothelial behavior, highlighting platelet-MVs as causative factors of impaired endothelial function in the acute phase of STEMI.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072657 ST Elevation Myocardial Infarction A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION). ST Elevated Myocardial Infarction,ST Segment Elevation Myocardial Infarction,STEMI
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D055252 Cell-Derived Microparticles Extracellular vesicles generated by the shedding of CELL MEMBRANE blebs. Cell Membrane Microparticles,Circulating Cell-Derived Microparticles,Ectosomes,Microparticles, Cell-Derived,Shedding Microvesicles,Cell Derived Microparticles,Cell Membrane Microparticle,Cell-Derived Microparticle,Cell-Derived Microparticle, Circulating,Cell-Derived Microparticles, Circulating,Circulating Cell Derived Microparticles,Circulating Cell-Derived Microparticle,Ectosome,Membrane Microparticle, Cell,Membrane Microparticles, Cell,Microparticle, Cell Membrane,Microparticle, Cell-Derived,Microparticle, Circulating Cell-Derived,Microparticles, Cell Derived,Microparticles, Cell Membrane,Microparticles, Circulating Cell-Derived,Microvesicle, Shedding,Microvesicles, Shedding,Shedding Microvesicle

Related Publications

Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
November 2018, Thrombosis and haemostasis,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
June 2022, Journal of human hypertension,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
February 2009, Blood,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
January 2017, Frontiers in cardiovascular medicine,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
January 2016, Tsitologiia,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
January 2013, PloS one,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
January 2018, Nutrition & metabolism,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
January 1998, Cardiovascular research,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
January 2019, Frontiers in medicine,
Marta Brambilla, and Maria Talmon, and Paola Canzano, and Luigia G Fresu, and Sandra Brunelleschi, and Elena Tremoli, and Marina Camera
December 2020, The FEBS journal,
Copied contents to your clipboard!